Zydus gets USFDA tentative nod for Empagliflozin Tablets Medical Dialogues Bureau11 April 2020 6:47 AM GMTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD: Ja...
Zydus gets USFDA nod for Lamotrigine Extended-Release Tablets for seizures Medical Dialogues Bureau3 April 2020 8:02 AM GMTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Lamotrigine Extended-Release Tablets USP in the strengths of 25 mg, 50 mg,...
Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules Medical Dialogues Bureau31 March 2020 8:00 AM GMTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of...
Cadila Healthcare BOD approves transfer of Animal Healthcare Business to Zydus Animal Health and Investments Limited Medical Dialogues Bureau15 March 2020 3:30 AM GMTNew Delhi: Cadila Healthcare Ltd. has recently announced that the Board of Directors at its meeting, has approved the transfer of Animal Healthcare Bus...
Zydus, XOMA enter into licensing agreement for IL-2-Based Immuno-Oncology Therapy Medical Dialogues Bureau11 March 2020 3:30 AM GMTAhmedabad, Emeryville: Zydus Cadila and XOMA Corporation have announced they have entered into a licensing agreement to advance an IL-2-based immuno-on...
Zydus gets DCGI nod for Phase I clinical trial of ZYBK2b to treat Rheumatoid Arthritis Medical Dialogues Bureau4 March 2020 5:04 AM GMTZYBK2 has been specifically designed to inhibit HLA-DRB1 Shared Epitope (SE) that determines the susceptibility of a person to develop rheumatoid...
